New Proposed HSR Changes and the Impact on Private Equity: Intensified Scrutiny, Increased Reporting Requirements
Navigating the Issues These Changes Present for Fund Managers and Actions to Take Now to Address the Challenges Ahead
Recording of a 90-minute premium CLE video webinar with Q&A
This CLE webinar will discuss the proposed changes to the Hart-Scott-Rodino (HSR) form and instructions and their significant impact on private equity firms. The panel will identify key changes the proposed new form would bring, issues and challenges these changes create, and strategies practitioners can take now to address the challenges ahead.
Outline
- Overview of the proposed rule changes
- Key changes that will directly impact private equity
- Overlap narratives
- Prior transactions
- Provision of documents
- Ultimate parent entity information
- Other generally applicable provisions that will likely result in more significant reporting requirements for private equity firms
- Proactive measures private equity sponsors can take now to prepare for the new rules
- Key takeaways
Benefits
The panel will address these and other key issues:
- What provisions of the new rules directly target private equity firms?
- How will other generally applicable rules impact private equity firms?
- What are the potential implications of the new rules on future deals and transactions?
- What actions should private equity firms take now in contemplation of the new rules?
Faculty
Danielle Asaad
Partner
Squire Patton Boggs
Ms. Asaad represents private equity sponsors and corporate clients in connection with acquisitions, minority... | Read More
Ms. Asaad represents private equity sponsors and corporate clients in connection with acquisitions, minority investments, divestitures, joint ventures, financings, restructurings and other corporate matters. She has completed numerous complex transactions on behalf of many sophisticated private equity firms, including leveraged buyouts and co-investments. Ms. Asaad has also represented private equity firms and their portfolio companies in related matters, including financings, recapitalizations, follow-on acquisitions, joint ventures, dispositions, dual track exits, carve-outs, corporate governance and management incentive plans.
Close
Christopher Gordon
Partner
Squire Patton Boggs
Mr. Gordon’s practice includes handling both civil and criminal litigation matters as well as federal and state... | Read More
Mr. Gordon’s practice includes handling both civil and criminal litigation matters as well as federal and state government investigations; representing clients in mergers and acquisitions before the FTC, Antitrust Division of the DOJ and state competition authorities; and counseling clients on a variety of joint venture and marketing and distribution practices. He has extensive experience in developing and implementing global antitrust compliance programs and has handled diverse matters involving consumer protection issues, advertising and trade association activities.
Close
Jesse Solomon
Partner
Davis Polk & Wardwell
Mr. Solomon routinely represents clients in antitrust investigations of complex, high-profile transactions and in... | Read More
Mr. Solomon routinely represents clients in antitrust investigations of complex, high-profile transactions and in non-merger conduct investigations before the Federal Trade Commission and the U.S. Department of Justice. In his M&A advisory practice, Mr. Solomon develops global strategies for obtaining competition clearance of transactions across international jurisdictions, with particular experience in transactions in the pharmaceuticals, healthcare, technology, chemicals and consumer products industries. He has been the lead partner for clients in some of the largest and most challenging antitrust investigations in recent history.
Close